Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Pharmacological Device Delivers Powerful Drugs Safely

By HospiMedica International staff writers
Posted on 21 Apr 2011
A novel drug-delivery device under development could unlock the potential of photosensitive chemicals to kill drug-resistant infections, and perhaps destroy cancer tumors as well.

Researchers at the University of California (UCI; Irvine, USA) and Jiao Tong University (Shanghai, China) developed an optical fiber-based device that can deliver very small amounts of photosensitive chemicals to internal organs with pinpoint accuracy. More...
The device consists of three components. The first, a charge-coupled device (CCD) similar to that in digital cameras; it enables a physician to guide the device to the infection. The second, a flexible optical fiber one-millimeter in diameter attached to a micro sized high-power light emitting diode (LED) or laser diode that provides the light for the CCD; once the physician positions the device, the same light source shines with greater intensity to activate the medicine.

The third component is a hollow tube connected to a syringe that delivers the medicine to the infection; glycol, a thickening agent used in surgical soaps, is added to keep the medicine from spreading to healthy cells. Pulling back the syringe creates a vacuum that sucks up any remaining chemical after the procedure. The instrument can utilize light in wavelengths varying from deep ultraviolet (UV) to infrared (IR) to induce photoreactions of the drug with the pathogen of the infected area.

The compact system utilizes much smaller quantities of drugs or radiation dose than conventional methods, eliminates the need for intravenous injection, and greatly decreases the toxic effects of drugs and irradiation to the human body including swelling, inflammation, nausea, fever, and sunlight sensitivity that can last for about 30 days. The study presenting the system was published in the January 2011 issue of the American Institute of Physics (AIP) Review of Scientific Instruments.

"We can insert the instrument through the nose, bowels, mouth, or almost any opening and direct it where we want,” said codeveloper professor of chemistry Peter Rentzepis, PhD. "It lets us deliver very small amounts of these chemicals right to an infection or tumor, then remove them before they damage healthy cells.”

Related Links:

University of California Irvine
Jiao Tong University




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.